Resampling the N9741 Trial to Compare Tumor Dynamic Versus Conventional End Points in Randomized Phase II Trials
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 33 (1) 36-41
Year:
2015
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
4
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, UL1 TR000430, K12CA139160, K12 CA139160, P30 CA014599, P30CA014599, U10 CA180821, U10 CA180850, P30 CA015083, U10 CA180882  
Corr. Author:
 
Authors:
           
Networks:
 
Study
NCCTG-N9741
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Bios3, Gic5, Stat, ORIGINAL REPORTS, Statistical Analysis